Carey Robert M
Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA.
Curr Hypertens Rep. 2017 Mar;19(3):21. doi: 10.1007/s11906-017-0720-7.
Angiotensin type-2 receptors (AT2Rs) in the renal proximal tubule inhibit sodium (Na+) reabsorption by inducing renal cyclic GMP formation and internalizing and inhibiting major Na+ transporters Na+-H+ exchanger-3 (NHE-3) and Na+/K+ATPase (NKA). Instead of angiotensin II (Ang II), angiotensin III (Ang III) is the predominant endogenous agonist for this response. Exogenous non-peptide AT2R agonist Compound-21 induces natriuresis and lowers blood pressure (BP) in normal and Ang II-infused hypertensive rodents. Spontaneously hypertensive rats (SHR; both pre-hypertensive and hypertensive) have defective natriuretic responses to Ang III, suggesting a defect in AT2R-mediated natriuresis in SHR that leads to hypertension. The mechanisms of deficient AT2R-mediated natriuresis in SHR are unknown but could involve either pre-receptor or receptor/post-receptor defects.
肾近端小管中的血管紧张素2型受体(AT2Rs)通过诱导肾环磷酸鸟苷生成以及使主要的钠转运蛋白钠-氢交换体3(NHE-3)和钠/钾ATP酶(NKA)内化并抑制其功能,从而抑制钠(Na+)重吸收。对于这一反应,血管紧张素III(Ang III)而非血管紧张素II(Ang II)是主要的内源性激动剂。外源性非肽类AT2R激动剂化合物-21可在正常和输注Ang II的高血压啮齿动物中诱导利钠作用并降低血压(BP)。自发性高血压大鼠(SHR;包括高血压前期和高血压期)对Ang III的利钠反应存在缺陷,提示SHR中AT2R介导的利钠作用存在缺陷,这会导致高血压。SHR中AT2R介导的利钠作用不足的机制尚不清楚,但可能涉及受体前或受体/受体后缺陷。